Skip to content


More than 1,000 eye care professionals worldwide have been using the AdaptDx® and AdaptDx Pro® to test for impaired dark adaptation, the earliest biomarker of age-related macular degeneration. Our customers tell the story of how they’re fighting against preventable blindness by identifying AMD at its earliest stages and closely monitoring its progression. 

We have a large retirement population here in Myrtle Beach, so we see a lot of AMD. We invested in the AdaptDx because we know it’s going to help us take better care of our AMD patients, as well as identify so many others who are at risk for developing this devastating disease.

Tammy Tully 2 Tammy Tully, OD

Dark adaptation testing has been a great addition to my office. This device helps me find patients with AMD much sooner than we've ever been able to do. We know that 1 out of 3 Americans over the age of 75 has some form of AMD. But why wait until it's obvious to start therapy?

Jacob Olding, OD Jacob Olding, OD

If you had a crystal ball to predict glaucoma, diabetic retinopathy or AMD, would you not take advantage of it? We have early diagnostic strategies for all three. Ganglion cell loss and capillary density reduction are sentinels for glaucoma and diabetic retinopathy, respectively. Impaired dark adaptation is the gold standard biomarker for subclinical AMD.

Leo Semmes, OD, FAAO Leo Semes, OD, FAAO

Our doctors decided that we should be doing AMD screening for our patients over the age of 65, no matter what. Photos and looking at the macula is just not enough. If you look at the statistics, it makes more sense to do an AdaptDx test on this population than it does to take a tonometry reading to screen for glaucoma!! We decided we wanted to be more proactive and take better care of our patients. Using the AdaptDx to measure dark adaptation function, the earliest sign of AMD, enables us to do just that.

Laurie Sorrenson, OD, FAAO Laurie Sorrenson, OD, FAAO

If you want to impact your patient base in a very positive way by diagnosing and treating macular degeneration at the earliest stages possible to best preserve long term vision, then the AdaptDx is an absolute necessity. There is no other way to detect impairment consistent with AMD so early, including by the best dilated examination and imaging you can give as an eye doctor. Think of it this way…you go to your PCP once per year. And once per year your PCP orders lab work to look for disease that is asymptomatic and undetectable to them in any other way in the early stages (high cholesterol, diabetes, thyroid dysfunction). This is what the AdaptDx can do for your patients.

AmandaLegge_OD Amanda Legge, OD

I have been in eye care since the late 90s and I remember that macular degeneration was just a condition that was very difficult to detect and even once detected, it was difficult to do anything about it. So, essentially, we were just watching patients go blind. Now that we have the AdaptDx, it’s made a world of a difference in diagnosing patients.

Dannette Lammert Dannette Lammert, OD

I started using my AdaptDx this past July (2017), and it has already completely changed my approach to AMD for the better. In terms of both helping to detect undiagnosed AMD and confirming patients with early AMD, I can say with confidence that it's helping preserve future vision for my patients.

Mogyordy Pete Mogyordy, OD

The primary goal of every optometrist is to maximize and preserve the vision of their patients. The AdaptDx is the best device available for the earliest detection of reduced dark adaptation of the retina, usually secondary to AMD. Early detection gives my patients the best chance for long-term retention of their vision, thereby achieving their vision goals and my practice goals.

Brain Mathie Brian E Mathie, OD, FAAO

When we started using the AdaptDx, we weren’t sure how the technology was going to be received. But we found that using it in the office has made us better clinicians and has helped improve the quality of life for our patients. I honestly can’t see myself practicing without the AdaptDx at this point.

Tony Jacob Tony Jacob, OD

Since incorporating AdaptDx in our office, we can tell patients that – even though they have a family history or are concerned about the disease – we have a device that can help detect it before it is too late. Diagnosing AMD at the subclinical level allows us to put in place a plan of action for treatment. Having this plan brings comfort to not only myself but also the patients, so they can walk out my practice doors with a newfound confidence in their future.

imageedit_2_5947200268 Kent Godfrey, OD